Visakhapatnam node (Nakkapalli / Rambilli)
Click a corridor or node to open its dossier. Node positions are centroid-approximate. Satellite imagery © Esri, Maxar, Earthstar Geographics.
Visakhapatnam is the northern terminus of the VCIC and its most infrastructure-ready node, developed as two ADB-funded clusters — Rambilli and Nakkapalli — in Anakapalli district. The implementing SPV, Visakhapatnam Industrial Node Development Corporation Ltd, was incorporated in September 2018, and Rambilli land acquisition is already 95.7% complete.
What makes the node credible is what sits around it rather than inside it. The adjacent Jawaharlal Nehru Pharma City — 2,400+ acres, 104 firms including Pfizer, Mylan/Viatris, Eisai, PharmaZell, Aurobindo, Laurus Labs, Dr Reddy’s and Divi’s, employing ~30,000 — is the operational anchor the node integrates, while the ~₹1.4 lakh cr Nippon Steel–ArcelorMittal plant 8 km away and a proposed Google/Raiden data centre define its industrial gravity.
Inside the node boundary itself, confirmed activity is still thin: the one named allottee, Prana Pharmaceuticals, was non-operational and in cancellation proceedings by 2020, and the November 2025 CII Summit produced mostly statewide or multi-location MoUs (Champions Group) plus five unnamed bhoomi-puja companies. The construction is real; the in-boundary tenant list is not yet filled.
What this node pulls — supplier opportunity surface
Semiconductor & electronics
A fab or OSAT anchor pulls a ~500-supplier cascade: bulk utilities localise first, while electronic-grade materials, metrology and specialist services stay 75-98% import-dependent - the opportunity band.
| Layer | Status | What the anchor pulls | Import dep. | Entry |
|---|---|---|---|---|
| Ultrapure water (UPW) systems | Localised (strong Indian base) | Design, build, operate and zero-liquid-discharge for wafer/package plants | 45% | Build-now |
| Bulk gases (N2/O2/Ar) | Localised (Indian JVs active) | On-site air-separation and baseload gas supply | 30% | Build-now |
| Equipment calibration (NABL) & maintenance | Near-absent / OEM-captive | Accredited on-site calibration labs; spares + field service independent of AMAT/Lam/TEL | 90% | Build-now |
| Electronic specialty gases | Distributor-only for electronic grade | NF3/WF6/HCDS/C4F6 - captive on-site electronic-gas plants | 92% | Position-early |
| Electronic wet chemicals & CMP slurry | Distributor-only | Developers, precursors, slurry - import substitution | 88% | Position-early |
| Metrology, test & failure analysis | Service-led opening | Metrology-as-a-service labs for every fab/OSAT | 75% | Position-early |
| Cleanroom engineering & consumables | Partial (EPC local, materials imported) | HEPA/ULPA, garments, wipes, filter media | 60% | Position-early |
| Advanced packaging / OSAT services | Moving (Micron/Tata/Kaynes) | Assembly, test, substrate supply into anchor plants | 55% | Position-early |
| Photoresist & wafer handling (FOUPs) | Import-only | High-IP, long-horizon strategic items | 96% | Watch |
Pharma & bulk drugs
An API or pharma anchor pulls process-engineering depth - cleanrooms, solvent recovery, analytical labs - plus logistics that are heavily import-served today.
| Layer | Status | What the anchor pulls | Import dep. | Entry |
|---|---|---|---|---|
| Cleanroom EPC & HVAC | Local EPC exists | Class 100k-10k suites, materials partly imported | 50% | Build-now |
| Analytical & QC labs | Service-led opening | HPLC/GC, microbiology - every unit needs certified testing | 60% | Build-now |
| Specialty glass & primary packaging | Import-heavy | Vials, ampoules, stoppers, films | 75% | Position-early |
| API intermediates & solvents | Import-dependent | Backward integration into key starting materials | 80% | Position-early |
| Solvent recovery & ZLD water | Local base | Environmental compliance as a service business | 45% | Build-now |
| Cold-chain & pharma logistics | Localising | Temperature-controlled distribution | 55% | Position-early |
Indicative opportunity surface derived from the node's sector profile and Techadyant sector-level research (import-dependency figures from the Dholera supplier workbook and cross-report modelling). Not node-specific verified commitments — verify each layer against current tenders and anchor statements before acting. Entry tiers: Build-now (capital-light, local base exists), Position-early (gap to close), Watch (long-horizon, high-IP).
Companies & commitments
| Company | Sector | Commitment |
|---|---|---|
| Prana Pharmaceuticals Pvt Ltd | Bulk drugs / APIs — oncology, cardiovascular, anti-HIV, anti-diabetic | 10 ac at Plot 14A, Krishnampalem (Rambilli) — allotted 2014–15; non-operational, cancellation proceedings from Dec 2020 [V] (the only named allottee inside the node boundary) |
| Champions Group (Champion InfoMetrics / InfraTech) | Tech parks, GCCs, datacentre + Crystal Lagoon | ₹540 cr (tech parks/datacentre) + ₹225 cr (Crystal Lagoon) — MoU at CII Summit, Nov 2025 (Visakhapatnam & Amaravati) [V] |
| 5 unnamed companies (bhoomi puja, Visakhapatnam) | Mixed | ₹3,800+ cr combined · ~30,000 direct jobs — groundbreaking at CII Summit, Nov 2025; companies not named [V1] |
| Jawaharlal Nehru Pharma City (JNPC) — adjacent, not a VCIC allottee | Pharmaceuticals — API, formulations, CDMO | 2,400+ ac · 104 firms · ~30,000 employed — operational since 2010; the pre-existing base the node integrates [V] |
| Nippon Steel–ArcelorMittal plant — adjacent, not a VCIC allottee | Steel manufacturing | ~₹1.4 lakh cr · 6,500 ac · 1 lakh+ jobs — ~8 km from Rambilli, under construction/planned [V1] |
| Raiden Infotech / Google (proposed) — adjacent, not a VCIC allottee | Data centre | Proposed within ~2 km of Rambilli; the wider Google/Raiden AI data-centre plan is in Visakhapatnam/Anakapalli districts [V1] |
Industries coming up
Infrastructure & connectivity
- The node is two clusters: Rambilli (396.27 ac, of which 379.36 ac — 95.7% — already handed to APIIC) and Nakkapalli (1,089-ac/441-ha Phase I start-up area within a 4,386-ac/1,775-ha master plan). Nakkapalli Phase I sets aside ~571 ac (52.4%) for industrial plots and ~31 ac for residential/commercial use.
- ADB Tranche 2 (US$141.12 m loan; US$214.80 m total project cost) funds internal roads, storm-water drains, bulk water supply, power distribution and a CETP; external works include widening the 13.8 km Atchuthapuram–Anakapalli road to NH-16 and a 4.4 km access road to Nakkapalli. The MFF availability window runs to 19 September 2026.
- Water for Nakkapalli is drawn from the Yeluru Left Main Canal via a summer storage tank and treatment plant; power from the Chandanada substation through APTRANSCO. A CETP is to be built by APIIC after the trunk infrastructure.
- Connectivity is the node’s strongest card: NH-16 (Golden Quadrilateral), Visakhapatnam Port 20–40 km, Visakhapatnam Airport ~40 km, Elamanchili rail station 10–12 km, plus a proposed coastal-corridor road and a proposed Rambilli port; the Adani Gangavaram Port and INS Varsha naval base are in the wider region.
Incentives & land: No node-specific fiscal incentive framework was found — VCIC/ADB support here is infrastructure-in-kind (roads, drains, water, power, CETP) rather than cash incentives. Units fall under general Andhra Pradesh industrial policy and APIIC’s 2015 industrial-parks allotment regulations, with single-window clearance; sector-specific bulk-drug incentives apply to pharma units. Market land rates near the node (Achyutapuram SEZ) are reported around ₹6 cr per acre, distinct from the official APIIC allotment rate (not published).
Two clusters under ADB finance
The node is being built as Rambilli (396.27 ac, 379.36 ac handed over) and Nakkapalli (1,089-ac Phase I within a 4,386-ac master plan), with internal and external infrastructure funded by ADB’s VCIC Development Program Tranche 2 (US$141.12 m loan, US$214.80 m total). The MFF window closes in September 2026, which puts a clock on trunk-works completion.
Target sectors are pharmaceuticals (anchored by JNPC), transport equipment (synergy with the steel plant), electronics/IT and textiles. The land-acquisition footprint is socially sensitive: 63 families (173 persons) are affected at Rambilli, 24% from vulnerable SC/OBC groups.
The adjacent base — JNPC, steel and data
Jawaharlal Nehru Pharma City at Parawada is the real industrial engine in this corridor segment — a 2,400-acre integrated pharmaceutical cluster operational since 2010, built as an APIIC–Ramky PPP (Visakha Pharmacity Ltd), now hosting 104 companies and ~30,000 workers with US FDA, EMA, MHRA and WHO-GMP compliance. It predates the VCIC designation and is not a node allottee, but it is what the node is designed to feed off.
The ~₹1.4 lakh cr Nippon Steel–ArcelorMittal plant (6,500 ac, 8 km away) and a proposed Google/Raiden data centre within ~2 km give the node a transport-equipment and electronics pull that no other VCIC node has.
Risks & open questions
The in-boundary tenant pipeline is the weak point: the only named allottee, Prana Pharmaceuticals, never commissioned its 10-acre bulk-drug plant and faced cancellation from 2020 — a cautionary precedent for allottee discipline. No operational industry has been identified within the Rambilli or Nakkapalli start-up areas themselves.
Open items include the node’s environmental-clearance status, the Nakkapalli plot allotment list, the official APIIC allotment price, whether the Google data centre is formally approved, and whether the CETP has been funded and bid out before the ADB window closes in September 2026.
Timeline
- Sep 2016ADB VCIC Tranche 1 approved
- Sep 2018Visakhapatnam Industrial Node Development Corporation Ltd incorporated
- 2020Prana Pharmaceuticals cancellation proceedings (AP High Court, WP 24092/2020)
- Apr 2023ADB Tranche 2 (US$141.12 m) voting; Rambilli 95.7% acquired
- Nov 2025CII Partnership Summit hosted at Visakhapatnam (Champions Group MoU; 5 bhoomi-puja firms)
- Sep 2026ADB MFF availability window closes — trunk-works deadline
Sources
- Express Pharma — JNPC, a 20-year legacy ↗
- APIIC — JNPC PPP document ↗
- The Hindu — AP attracts ₹13.25 lakh cr at CII Summit ↗
- Lokmat Times — Champions Group projects at CII Summit ↗
- Deccan Chronicle — AP hosts CII Summit (bhoomi puja, 5 firms) ↗
- Business Standard — CII Summit investments ↗
- The Hindu (2007) — Pharma City set to become operational ↗